iShares Biotechnology ETF Rating $127.86 -0.93 (-0.72%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$127.49 -0.37 (-0.29%) As of 06:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.70Holdings in IBB have an aggregate rating of Moderate Buy based on 2,344 analyst ratings issued in the past year covering 242 companies (99.8% of the portfolio).IBB Aggregate Price Target$127.86High Prediction$127.86Average Prediction$127.86Low Prediction$127.86Holdings in IBB have an aggregate price target of $127.86 and a range of $127.86 to $127.86 covering 242 companies (99.8% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy2 Strong Buy rating(s)Buy105 Buy rating(s)Moderate Buy90 Moderate Buy rating(s)Hold40 Hold rating(s)Reduce5 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 100 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.45%GILDGilead Sciences$109.30-0.7%4.8758 of 5 stars2.78$110.55 1.1%27Trending NewsAnalyst Revision8.26%AMGNAmgen$291.81-0.6%4.4666 of 5 stars2.38$309.22 6.0%24Positive NewsAnalyst Revision8.24%VRTXVertex Pharmaceuticals$452.44+0.2%4.5827 of 5 stars2.57$515.04 13.8%30Positive NewsAnalyst Revision5.89%REGNRegeneron Pharmaceuticals$518.60-0.9%4.8664 of 5 stars2.85$836.48 61.3%26Analyst ForecastAnalyst Revision4.36%ALNYAlnylam Pharmaceuticals$298.58-1.3%4.2811 of 5 stars2.77$319.17 6.9%26Positive News2.97%IQVIQVIA$158.82-0.6%4.8707 of 5 stars2.75$226.32 42.5%24Short Interest ↑2.79%ARGXargenx$574.96-0.1%3.6415 of 5 stars3.05$709.18 23.3%22Analyst Forecast2.78%MTDMettler-Toledo International$1,192.00-2.0%3.7252 of 5 stars2.40$1,302.11 9.2%10Positive News2.46%NTRANatera$166.76+0.9%2.0496 of 5 stars3.00$184.63 10.7%15Positive NewsInsider Trade2.41%WATWaters$346.59-0.9%4.1873 of 5 stars2.61$390.19 12.6%18Trending News2.21%BIIBBiogen$133.06-1.8%4.766 of 5 stars2.38$191.30 43.8%322.09%BNTXBioNTech$105.46-1.3%2.9086 of 5 stars2.83$138.25 31.1%18Analyst Revision1.65%UTHRUnited Therapeutics$276.47-1.7%4.9943 of 5 stars2.69$393.08 42.2%13Trending NewsAnalyst ForecastInsider TradeAnalyst RevisionHigh Trading Volume1.64%ONCBeigene$262.41-0.4%1.3903 of 5 stars3.00$319.00 21.6%6Trending NewsInsider TradeGap Up1.51%ILMNIllumina$87.54-0.5%4.9023 of 5 stars2.47$126.94 45.0%19Positive NewsAnalyst ForecastOptions Volume1.50%INSMInsmed$97.98+7.8%3.4771 of 5 stars3.00$104.81 7.0%18Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume1.48%INCYIncyte$68.85-1.7%4.4912 of 5 stars2.17$72.53 5.3%18Positive News1.39%NBIXNeurocrine Biosciences$124.17-0.5%4.8973 of 5 stars2.86$162.00 30.5%22Analyst Revision1.33%EXELExelixis$41.43-2.6%4.4736 of 5 stars2.47$39.35 -5.0%19Positive News1.22%BMRNBioMarin Pharmaceutical$57.16-0.6%4.9498 of 5 stars2.74$93.45 63.5%23Positive NewsAnalyst Revision1.16%GMABGenmab A/S$22.63-0.9%3.7647 of 5 stars2.69$39.17 73.1%13Positive NewsGap Up1.07%MRNAModerna$27.75+0.3%4.5312 of 5 stars2.04$46.61 68.0%23Trending News0.93%BPMCBlueprint Medicines$127.950.0%1.1972 of 5 stars2.32$129.35 1.1%22High Trading Volume0.90%MEDPMedpace$302.31-1.2%4.6796 of 5 stars2.23$349.30 15.5%13Positive News0.90%TECHBio-Techne$51.54+0.3%4.8676 of 5 stars2.45$72.00 39.7%110.84%ASNDAscendis Pharma A/S$171.72-0.4%3.5555 of 5 stars3.00$217.73 26.8%15Analyst ForecastAnalyst Revision0.84%CRLCharles River Laboratories International$151.02+0.0%4.7407 of 5 stars2.18$171.85 13.8%170.77%RGENRepligen$132.00-0.7%4.733 of 5 stars2.64$173.25 31.3%140.76%HALOHalozyme Therapeutics$53.85+0.1%4.915 of 5 stars2.17$61.90 14.9%12Positive News0.75%RVMDRevolution Medicines$40.79-2.8%4.4448 of 5 stars3.00$67.08 64.5%12Positive News0.65%BBIOBridgeBio Pharma$39.05-2.6%4.6239 of 5 stars2.92$57.36 46.9%12Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.63%IONSIonis Pharmaceuticals$36.19-1.8%4.4022 of 5 stars2.65$56.67 56.6%20Positive News0.60%MDGLMadrigal Pharmaceuticals$294.34+4.3%4.3456 of 5 stars2.89$420.63 42.9%9Positive NewsAnalyst Revision0.58%ALKSAlkermes$31.20+0.5%4.2921 of 5 stars2.77$38.85 24.5%13Insider Trade0.57%ROIVRoivant Sciences$11.28-0.8%2.3781 of 5 stars3.00$17.50 55.1%40.56%TEMTempus AI$70.78+2.0%1.7138 of 5 stars2.54$63.42 -10.4%13Trending NewsHigh Trading Volume0.53%ADMAADMA Biologics$21.87+4.8%2.1869 of 5 stars3.25$24.25 10.9%4Trending NewsInsider TradeAnalyst Revision0.50%AXSMAxsome Therapeutics$108.08-1.7%4.6999 of 5 stars3.06$172.80 59.9%16Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.49%PCVXVaxcyte$35.44-4.7%2.82 of 5 stars3.10$136.50 285.2%10Analyst Revision0.49%VRNAVerona Pharma$90.05+3.8%2.3658 of 5 stars3.10$87.44 -2.9%10Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.45%BRKRBruker$39.72-2.3%4.9605 of 5 stars2.40$56.22 41.5%10Insider Trade0.45%PTCTPTC Therapeutics$50.82-1.8%4.3441 of 5 stars2.64$63.75 25.4%14Analyst Revision0.44%LEGNLegend Biotech$36.59-2.8%3.0745 of 5 stars2.91$76.20 108.3%11Trending NewsShort Interest ↑Analyst Revision0.44%RNAAvidity Biosciences$32.01-4.8%2.1688 of 5 stars3.07$67.33 110.4%15Trending NewsAnalyst ForecastAnalyst Revision0.43%CYTKCytokinetics$33.11-4.1%4.4251 of 5 stars2.93$70.92 114.2%15Trending NewsAnalyst ForecastAnalyst Revision0.42%RYTMRhythm Pharmaceuticals$64.84-3.8%4.1934 of 5 stars3.00$76.62 18.2%13Insider Trade0.41%AKROAkero Therapeutics$52.96-2.9%3.6426 of 5 stars3.00$82.50 55.8%7Insider TradeOptions Volume0.41%ACADACADIA Pharmaceuticals$22.30+0.5%3.242 of 5 stars2.69$26.79 20.1%16Trending NewsAnalyst Revision0.41%MRUSMerus$55.05-2.5%3.2445 of 5 stars3.13$85.83 55.9%150.41%SRPTSarepta Therapeutics$37.81-3.2%4.8276 of 5 stars2.87$122.61 224.3%230.39%NUVLNuvalent$76.91-3.2%2.4074 of 5 stars2.90$115.50 50.2%10Positive News0.38%SWTXSpringWorks Therapeutics$46.75+0.0%1.6116 of 5 stars2.13$52.57 12.5%8Positive News0.37%KRYSKrystal Biotech$139.62+1.0%4.6884 of 5 stars3.00$211.13 51.2%9Positive NewsAnalyst Revision0.36%CRSPCRISPR Therapeutics$41.52-3.3%3.3025 of 5 stars2.50$71.75 72.8%18Analyst Revision0.36%RAREUltragenyx Pharmaceutical$37.514.3634 of 5 stars2.92$88.77 136.7%13Analyst Revision0.34%PTGXProtagonist Therapeutics$55.34-1.8%2.0165 of 5 stars3.00$65.44 18.3%9Insider Trade0.32%CRNXCrinetics Pharmaceuticals$32.33-2.3%3.5614 of 5 stars2.91$74.56 130.6%11Positive NewsAnalyst Revision0.31%ZLABZai Lab$41.40+3.5%1.4827 of 5 stars2.75$47.37 14.4%4Positive NewsAnalyst Revision0.30%ACLXArcellx$66.17-0.7%2.6591 of 5 stars3.07$111.33 68.3%14Insider TradeAnalyst Revision0.28%KYMRKymera Therapeutics$48.39-0.4%2.3065 of 5 stars3.00$59.82 23.6%180.26%SMMTSummit Therapeutics$19.58-11.3%2.9756 of 5 stars2.92$35.09 79.2%12Trending NewsAnalyst ForecastAnalyst RevisionGap Down0.26%SRRKScholar Rock$33.01-4.1%4.5289 of 5 stars3.14$42.67 29.3%7Positive News0.26%XENEXenon Pharmaceuticals$32.26+0.3%3.6872 of 5 stars3.00$54.82 69.9%12Options VolumeAnalyst RevisionHigh Trading Volume0.25%BCRXBioCryst Pharmaceuticals$10.61-3.6%4.3605 of 5 stars2.89$16.56 56.0%9Positive NewsAnalyst Revision0.25%VCELVericel$44.18-3.3%2.6777 of 5 stars3.00$61.14 38.4%7Positive News0.24%VCYTVeracyte$27.93+0.2%4.0088 of 5 stars2.70$40.90 46.4%10Positive News0.22%AGIOAgios Pharmaceuticals$34.41-0.3%4.1347 of 5 stars2.63$56.50 64.2%8Positive NewsAnalyst Revision0.22%APLSApellis Pharmaceuticals$19.27-1.6%4.7675 of 5 stars2.62$40.05 107.8%21Positive NewsAnalyst Revision0.21%FOLDAmicus Therapeutics$6.14+0.5%3.997 of 5 stars2.70$16.22 164.2%100.21%DNLIDenali Therapeutics$15.19-0.5%4.3576 of 5 stars3.06$33.71 122.0%17Positive NewsAnalyst Revision0.20%ARWRArrowhead Pharmaceuticals$16.74-1.4%3.6102 of 5 stars2.75$43.71 161.1%8Analyst Revision0.20%IDYAIDEAYA Biosciences$21.92-3.1%4.0159 of 5 stars2.93$54.27 147.6%14Positive NewsAnalyst Revision0.20%MIRMMirum Pharmaceuticals$48.46-1.1%3.8483 of 5 stars3.17$60.73 25.3%12Analyst Revision0.20%TWSTTwist Bioscience$35.15+2.0%4.1492 of 5 stars2.70$50.40 43.4%100.19%GRFSGrifols$8.95-0.8%3.6544 of 5 stars3.5020.19%NVCRNovoCure$17.36-5.5%4.0637 of 5 stars2.67$32.83 89.1%60.18%VERAVera Therapeutics$22.10-2.3%2.8949 of 5 stars3.10$65.00 194.1%10Short Interest ↑Analyst Revision0.17%BEAMBeam Therapeutics$17.89-1.1%3.2857 of 5 stars3.00$48.75 172.5%15Positive NewsAnalyst Revision0.17%RXRXRecursion Pharmaceuticals$5.40-0.9%1.9416 of 5 stars2.33$7.60 40.7%6Trending NewsGap UpHigh Trading Volume0.16%ETNB89bio$10.04-2.3%2.7281 of 5 stars3.00$26.43 163.2%8News CoverageAnalyst ForecastAnalyst Revision0.16%ADPTAdaptive Biotechnologies$10.63+1.6%2.7262 of 5 stars2.83$9.83 -7.5%6Positive News0.16%ARQTArcutis Biotherapeutics$13.73-1.2%2.0796 of 5 stars2.83$18.80 36.9%6Positive News0.16%TARSTarsus Pharmaceuticals$40.96-0.5%2.3744 of 5 stars3.00$66.67 62.8%7Positive News0.16%BHVNBiohaven$15.65-6.8%3.0204 of 5 stars3.07$59.46 280.1%15Trending NewsShort Interest ↑Analyst Revision0.15%APGEApogee Therapeutics$42.44+1.0%2.1544 of 5 stars3.00$94.60 122.9%5High Trading Volume0.15%MNKDMannKind$3.88-1.0%3.0781 of 5 stars3.25$10.00 157.7%8Trending NewsInsider TradeAnalyst Revision0.15%TVTXTravere Therapeutics$14.52-4.0%2.5276 of 5 stars2.87$32.14 121.4%15Trending NewsAnalyst ForecastAnalyst Revision0.14%DVAXDynavax Technologies$10.18-2.4%4.1705 of 5 stars2.50$24.00 135.8%4Positive News0.14%CGONCG Oncology$26.18-4.7%2.4986 of 5 stars3.00$58.22 122.4%11Positive NewsAnalyst Revision0.14%ALVOAlvotech$10.11-2.5%1.7082 of 5 stars3.00$18.00 78.0%2Short Interest ↑High Trading Volume0.14%JANXJanux Therapeutics$25.46-3.0%2.3999 of 5 stars3.09$95.25 274.1%11Positive NewsAnalyst Revision0.13%GRALGrail$43.87+4.1%0.5168 of 5 stars2.25$31.50 -28.2%40.13%DYNDyne Therapeutics$14.57-1.4%2.6536 of 5 stars3.00$44.93 208.4%15Analyst Forecast0.13%IMCRImmunocore$35.56-1.0%2.9203 of 5 stars2.55$58.89 65.6%11Analyst Revision0.13%NAMSNewAmsterdam Pharma$20.50-6.1%2.9856 of 5 stars3.00$43.00 109.8%7Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.13%STVNStevanato Group€24.77+0.5%2.2721 of 5 stars2.867Positive News0.12%EWTXEdgewise Therapeutics$15.75+1.9%2.861 of 5 stars2.78$39.78 152.6%9Positive News0.12%IMVTImmunovant$16.15-3.5%1.5912 of 5 stars2.90$38.33 137.4%10Positive NewsAnalyst Revision0.12%IRONDisc Medicine$50.86-4.2%2.3938 of 5 stars3.09$96.70 90.1%11Positive NewsAnalyst ForecastInsider TradeAnalyst Revision0.12%MESOMesoblast$11.87-6.6%2.3496 of 5 stars3.00$18.00 51.6%4News CoverageAnalyst Revision This page (NASDAQ:IBB) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IBB Stock Free IBB Stock Alerts